Management of Skin Rash During Egfr-Targeted Monoclonal Antibody Treatment for Gastro Intestinal Malignancies: Canadian Recommendations

Current Oncology - Canada
doi 10.3747/co.v16i1.361
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes From the HER1/EGFR Inhibitor Rash Management Forum

Oncologist
Cancer ResearchMedicineOncology
2005English

Multidisciplinary Canadian Consensus Recommendations for the Management and Treatment of Hepatocellular Carcinoma

Current Oncology
Oncology
2011English

EGFR Monoclonal Antibody Panitumumab Inhibits Chronic Proliferative Cholangitis by Downregulating EGFR

International Journal of Molecular Medicine
MedicineGenetics
2019English

Antibody-Targeted Immunocarriers for Cancer Treatment

2016English

Gastro-Intestinal Tract Complications During Antithrombotic Therapy

Obshchaya Reanimatologiya
Critical CareIntensive Care Medicine
2018English

Intravenous Immunoglobulin for Treatment of Gastro- Intestinal Haemorrhage in Dermatomyositis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2001English

Canadian Recommendations for the Management of Breakthrough Cancer Pain

Current Oncology
Oncology
2016English

Acute Staphylococcal Gastro-Enteritis With Rash, the Complication Induced by Antibiotic Treatment

Japanese Journal of Medical Science and Biology
1955English

Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

Current Oncology
Oncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy